Researchers turn to surprisingly simple method to combat deadly heat waves — here's how it works
Ahmedabad is one of India's hottest cities, with as many as 85 days of extreme heat each year, according to CSE data shared by The Times of India.
A team from Germany's University of Heidelberg received funding from the U.K.-based Wellcome Trust — a charity dedicated to solving global health crises — for the roof project.
Wellcome Trust's grants have also funded projects to determine links between Alzheimer's and menopause and to use reverse genetics to better understand chronic conditions.
The trial in Ahmedabad aims to determine how high temperatures affect overall health. To test this, each home in the study had its roof painted with a white reflective coating, known as a "cool roof," reported Reuters. These roofs reflect the sun's rays instead of absorbing them and heating homes.
Ahmedabad is known for having extreme heat spells, with many days from April to June exceeding 100 degrees Fahrenheit, per Weather Spark.
While much of India is hot, especially during the summer months, highly populated cities like Ahmedabad tend to be more vulnerable to high temperatures. The heat island effect causes daytime temperatures to trend higher in urban areas due to heat-absorbing materials and fewer trees and water to cool things off.
Activities like burning dirty fuels and cutting down forests have sped up the rise in temperatures around the globe. These human-driven actions release large amounts of planet-warming gases such as carbon dioxide, which trap heat in the atmosphere.
Places like Ahmedabad tend to feel the effects of these activities even more than other areas. A 2018 study published in the Scientific Reports journal noted that if global temperatures rise by just 2 degrees Celsius (3.6 degrees Fahrenheit) India could see six times as many heatwaves.
Extreme heat in Ahmedabad and other regions in India has increased hospitalizations and deaths. A 2024 study published in the Dialogues in Health journaI found that extreme heat in India contributed to cardiac, skin, and vector-borne diseases in addition to hyperthermia, heat strokes, and respiratory problems.
Do you think your home has good insulation?
Definitely
It's just all right
It's good in some rooms
Not at all
Click your choice to see results and speak your mind.
The "cool roof" project is designed to help researchers understand how much of a difference a cooler environment can make on health.
Reuters reported that the project will last for one year, with researchers collecting health and environmental information from participants and non-participants to compare notes. But some residents are already noticing a difference.
"My refrigerator doesn't heat up anymore and the house feels cooler," resident Nehal Vijaybhai Bhil told Reuters. "I sleep so much better and my electricity bill is down."
By cooling down homes, Ahmedabad residents could see fewer health-related issues. And in low-income areas of the city with limited or no access to air conditioning, staying cooler without extra appliances can be life-saving.
Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Roche considering selling drugs directly to US patients, CEO says
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part of talks with the U.S. government, which is pressuring drugmakers to cut prices, Roche's CEO said on Thursday. A direct-to-consumer (DTC) model would work for all of the Swiss company's medicines, CEO Thomas Schinecker said on a call with reporters, without detailing how the scheme might work. U.S. President Donald Trump issued an executive order in May directing drugmakers to lower medicine prices to align with what other countries pay. Last week, Bristol Myers and Pfizer said they would begin selling their blockbuster blood thinner, Eliquis, directly to cash-paying U.S. patients at a discount. Typically, U.S. drug prices are shaped by complex negotiations involving pharmacy benefit managers that act as middlemen between drugmakers and consumers. They negotiate volume discounts and fees with drugmakers on behalf of employers and health plans, create lists of drugs that are covered by insurance, and reimburse pharmacies for prescriptions. The system has often been criticised for inflating costs. An industry source told Reuters on Wednesday that the most viable DTC candidates were small-molecule drugs dispensed at retail pharmacies - such as treatments for diabetes, cardiovascular conditions, or respiratory diseases like asthma - because they are simpler to distribute and price directly for patients compared to complex medicines, such as some cancer drugs, which often require special handling and injection. Eli Lilly and Novo Nordisk already offer their popular weight-loss drugs Zepbound and Wegovy directly to U.S. patients for rates below the drugs' list prices. Lilly's chief financial officer, Lucas Montarce, said at an industry conference last month that the company had shared details of how it implemented its DTC model with the Trump administration. Schinecker said a DTC model would help lower costs in the U.S. quickly by cutting out pharmacy benefit managers. The model could appeal not only to the uninsured or under-insured, but also to insured patients comparing the cost of accessing drugs through insurers with cash prices, the industry source said. For example, if a patient was required to pay $20 to an insurer for a drug with a list price of $100, a DTC offer would need to beat that to be attractive. Roche has also increased inventories to avoid potential disruptions from tariffs, Schinecker said. The company announced in April plans to invest $50 billion in the U.S. over the next five years. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases. Matchpoint said on Thursday it will use its technology to develop drugs that block the activity of a specific protein, helping to lower the production of inflammation-causing signals. The company will lead the research and drug development process, using the funding from Novartis. If Novartis exercises its option to exclusively license the program, the drugmaker will have global rights to develop and commercialize all products resulting from the collaboration. Matchpoint said it will receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, and development and commercial milestones. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
BBC and news agencies warn journalists in Gaza at risk of starvation
BBC News and three leading news agencies have expressed desperate concern for journalists in Gaza, who they say are increasingly unable to feed themselves and their families. Those reporting the conflict from Gaza now face starvation and "the same dire circumstances as those they are covering," a joint statement from BBC News, Agence France-Presse (AFP), Associated Press (AP) and Reuters said. "For many months, these independent journalists have been the world's eyes and ears on the ground in Gaza", it reads. International news outlets rely on local reporters within Gaza, as Israel does not allow foreign media, including BBC News, to send journalists into the territory. Live updates 'We are not close to famine, we are living it,' says Gaza doctor as UN warns of 'dire' crisis UK and 27 nations condemn Israel over 'inhumane killing' of Gaza civilians It comes as more than 100 international aid organisations and human rights groups have warned of mass starvation in Gaza. The full statement reads: "We are desperately concerned for our journalists in Gaza, who are increasingly unable to feed themselves and their families. "For many months, these independent journalists have been the world's eyes and ears on the ground in Gaza. They are now facing the same dire circumstances as those they are covering. "Journalists endure many deprivations and hardships in warzones. We are deeply alarmed that the threat of starvation is now one of them. "We once again urge the Israeli authorities to allow journalists in and out of Gaza. It is essential that adequate food supplies reach the people there." In a separate joint statement, Médecins Sans Frontières (MSF), Save the Children and Oxfam, said their colleagues and the people they serve were "wasting away". But Israel, which controls the entry of supplies into Gaza, has accused the charities of "serving the propaganda of Hamas". Since Sunday, 45 Palestinians have died as a result of malnutrition, according to Gaza's Hamas-run health ministry. Israel prevented aid deliveries to Gaza in early March following a two-month ceasefire. The blockade was partially lifted after nearly two months, but food and medicine shortages have worsened. Israel, along with the US, helped to establish a controversial new aid system run by the Gaza Humanitarian Foundation (GHF). Hundreds of killings have been recorded in the vicinity of GHF's aid sites since they began operating eight weeks ago. The World Health Organization has said that a quarter of Gaza's population is facing famine-like conditions, according to its assessments. On Wednesday, its director Tedros Adhanom Ghebreyesus said: "I don't know what you would call it other than mass starvation, and it's man-made. "And that's very clear, this is because of the blockade." Gazans 'wasting away' as mass starvation spreads, humanitarian groups warn Jeremy Bowen: Israel's allies see evidence of war crimes in Gaza mounting up The Today Debate: What can stop the war in Gaza